- Report
- November 2023
- 88 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- July 2023
- 149 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- May 2023
- 129 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- April 2023
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Clinical Trials
- June 2020
- 97 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- July 2023
- 73 Pages
Global
From €3500EUR$3,884USD£3,107GBP
The Vertigo Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Vertigo Drugs are used to treat vertigo, a condition characterized by a sensation of spinning or whirling. These drugs are typically used to reduce the symptoms of vertigo, such as dizziness, nausea, and vomiting. Common Vertigo Drugs include antihistamines, anticholinergics, and benzodiazepines. These drugs work by blocking the action of certain chemicals in the brain that cause vertigo.
Some companies in the Vertigo Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of Vertigo Drugs, including antihistamines, anticholinergics, and benzodiazepines. Additionally, some of these companies also produce other Central Nervous System Drugs, such as antidepressants and antipsychotics. Show Less Read more
